A. G. Alekseeva
Research Subjects
A. G. Alekseeva has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Vasiliy G. Kaleda
FSBSI Mental Health Research Centre
7 shared publications - Grigoriy I. Kopeyko
Mental Health Research Center
5 shared publications - Ekaterina V. Gedevani
Mental Health Research Center
4 shared publications - Olga A. Borisova
FSBSI “Mental Health Research Centre
4 shared publications - E. V. Smirnova
FSBSI “Russian Mental Health Research Center
3 shared publications - Svetlana A. Zozulya
Federal State Budgetary Scientific Institution “Russian Mental Health Research Center”, Moscow 115522, Russia
2 shared publications
Latest Publications
- Open Access
- 17 October 2026
- Published by Medical Informational Agency Publishers in Psychiatry (Moscow) (Psikhiatriya)
- Vol. 24 (4) , 93-102
Dynamics of Religiosity in Endogenous Psychoses with ReligiousDepressive-Delusional Syndrome: Clinical and Follow-Up Study
Background : it remains unclear whether religiosity in depressive-delusional states represents exclusively a pathoplastic factor or whether the patterns of its changes at different stages of the disease constitute an independent prognostic marker. The Aim was to identi cate patterns of religiosity transformation at various stages of the course of endogenous disorders accompanied by religious-depressive-delusional syndrome (RDDS), and to substantiate their differential diagnostic and prognostic signi cance. Patients and Methods : a total of 104 patients with endogenous mental disorders (F31.5, F33.3, F25.1, F20.01, F20.0 on ICD-10) with clinical picture RDDS were included. There are two groups of patients: a clinical group (n = 58) and a follow-up group ( n = 46; mean follow-up period 12.24 ± 2.7 years). Three typological variants of RDDS were identi ed: Type I (with predominance of affectcongruent depressive delusions) — 22 cases (21.2%), Type II (with acute sensory delusions) — 36 patients (34.6%). Type III (with predominance of Kandinsky–Clérambault syndrome) — 46 (44.2%) cases. Religiosity at the pre-manifest stage was assessed using the history analysis ( n = 58) based on G. Allport's religious orientation concept and C.Y. Glock's multidimensional model. The Centrality of Religiosity Scale (CRS; S. Huber) and the Religious Coping Scale (K. Pargament) were applied in remission and follow-up stages ( n = 46). Clinical-psychopathological, clinical-follow-up, psychometric, and statistical methods (χ 2 , Cramér's V) were used. Results : type-speci c patterns of religiosity dynamics were closely associated with disease follow-up outcome. Stable harmonious hyperreligiosity with a protective function developed (mean CRS score 4.1 [3.89; 4.37]) in Type I. Bidirectional changes in religious worldview were observed in Type II: in some cases religiosity declined (CRS subtype 1: 3.4 [3.33; 3.47]), in others it intensi ed (subtype 2: 4.1 [4.0; 4.2]). Pathological “patchwork” religiosity was found in Type III (CRS 4.48 [4.47; 4.6]), intricately associated with residual productive symptomatology. A statistically signi cant association was established between RDDS type and both the pattern of religiosity dynamics (χ 2 = 38.38; p < 0.001; V = 0.655) and follow-up outcome (χ 2 = 28.25; p < 0.001; V = 0.6). Conclusion : religiosity in religious depressive-delusional syndrome represents not only a pathoplastic factor determining the content of psychopathological experiences, but may also be regarded as a clinically signi cant indicator associated with the type of disease course and outcome, which substantiates the necessity of differentiated therapeutic management.
- 17 October 2026
- Published by Medical Informational Agency Publishers in Psychiatry (Moscow) (Psikhiatriya)
- Vol. 24 (4) , 93-102
Open AccessDynamics of Religiosity in Endogenous Psychoses with ReligiousDepressive-Delusional Syndrome: Clinical and Follow-Up Study
Background : it remains unclear whether religiosity in depressive-delusional states represents exclusively a pathoplastic factor or whether the patterns of its changes at different stages of the disease constitute an independent prognostic marker. The Aim was to identi cate patterns of religiosity transformation at various stages of the course of endogenous disorders accompanied by religious-depressive-delusional syndrome (RDDS), and to substantiate their differential diagnostic and prognostic signi cance. Patients and Methods : a total of 104 patients with endogenous mental disorders (F31.5, F33.3, F25.1, F20.01, F20.0 on ICD-10) with clinical picture RDDS were included. There are two groups of patients: a clinical group (n = 58) and a follow-up group ( n = 46; mean follow-up period 12.24 ± 2.7 years). Three typological variants of RDDS were identi ed: Type I (with predominance of affectcongruent depressive delusions) — 22 cases (21.2%), Type II (with acute sensory delusions) — 36 patients (34.6%). Type III (with predominance of Kandinsky–Clérambault syndrome) — 46 (44.2%) cases. Religiosity at the pre-manifest stage was assessed using the history analysis ( n = 58) based on G. Allport's religious orientation concept and C.Y. Glock's multidimensional model. The Centrality of Religiosity Scale (CRS; S. Huber) and the Religious Coping Scale (K. Pargament) were applied in remission and follow-up stages ( n = 46). Clinical-psychopathological, clinical-follow-up, psychometric, and statistical methods (χ 2 , Cramér's V) were used. Results : type-speci c patterns of religiosity dynamics were closely associated with disease follow-up outcome. Stable harmonious hyperreligiosity with a protective function developed (mean CRS score 4.1 [3.89; 4.37]) in Type I. Bidirectional changes in religious worldview were observed in Type II: in some cases religiosity declined (CRS subtype 1: 3.4 [3.33; 3.47]), in others it intensi ed (subtype 2: 4.1 [4.0; 4.2]). Pathological “patchwork” religiosity was found in Type III (CRS 4.48 [4.47; 4.6]), intricately associated with residual productive symptomatology. A statistically signi cant association was established between RDDS type and both the pattern of religiosity dynamics (χ 2 = 38.38; p < 0.001; V = 0.655) and follow-up outcome (χ 2 = 28.25; p < 0.001; V = 0.6). Conclusion : religiosity in religious depressive-delusional syndrome represents not only a pathoplastic factor determining the content of psychopathological experiences, but may also be regarded as a clinically signi cant indicator associated with the type of disease course and outcome, which substantiates the necessity of differentiated therapeutic management.
- 30 June 2026
- Published by PANORAMA Publishing House in Vestnik Nevrologii, Psihiatrii i Nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery)
- No. 7,p. 1116-1129
Depressive-delusional states with religious content (evolution of concepts and unresolved issues)
Depressive-delusional states with religious content represent a distinct clinical form of psychotic depression, characterized by a distinctive psychopathological presentation, therapeutic resistance, elevated suicidal risk, and an unfavorable prognosis relative to non-psychotic depressive disorders. Despite a lengthy history of clinical description, targeted systematic investigation of this subject has not been conducted. The present review is devoted to the systematization and analysis of Russian and international literature addressing the psychopathology, nosological differentiation, dynamics of religiosity, and therapeutic management of depressive-delusional states with religious content. Publications of historical, clinical-psychopathological, therapeutic, and rehabilitative orientation are examined. It has been established that depressive religious delusion does not represent a phenomenologically neutral coloring of psychosis: it exerts an independent effect on the course, therapeutic dynamics, and prognosis of endogenous disorders, and is associated with reduced treatment adherence, attenuated symptom reduction, and, in a proportion of cases, increased suicidal risk. Based on the reviewed literature, the principles of pharmacotherapy and psychosocial rehabilitation have been systematized with due consideration of patients’ religious worldview, including confessionally oriented forms of psychotherapeutic intervention; issues of instrumental clinical assessment of religiosity are also addressed. The analyzed data substantiate the necessity of conducting a targeted comprehensive study of depressive-delusional states with religious content, incorporating clinical and clinical-follow-up components, aimed at the development of differentiated approaches to the treatment and rehabilitation of this patient population.
- 30 June 2026
- Published by PANORAMA Publishing House in Vestnik Nevrologii, Psihiatrii i Nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery)
- No. 7,p. 1116-1129
Depressive-delusional states with religious content (evolution of concepts and unresolved issues)
Depressive-delusional states with religious content represent a distinct clinical form of psychotic depression, characterized by a distinctive psychopathological presentation, therapeutic resistance, elevated suicidal risk, and an unfavorable prognosis relative to non-psychotic depressive disorders. Despite a lengthy history of clinical description, targeted systematic investigation of this subject has not been conducted. The present review is devoted to the systematization and analysis of Russian and international literature addressing the psychopathology, nosological differentiation, dynamics of religiosity, and therapeutic management of depressive-delusional states with religious content. Publications of historical, clinical-psychopathological, therapeutic, and rehabilitative orientation are examined. It has been established that depressive religious delusion does not represent a phenomenologically neutral coloring of psychosis: it exerts an independent effect on the course, therapeutic dynamics, and prognosis of endogenous disorders, and is associated with reduced treatment adherence, attenuated symptom reduction, and, in a proportion of cases, increased suicidal risk. Based on the reviewed literature, the principles of pharmacotherapy and psychosocial rehabilitation have been systematized with due consideration of patients’ religious worldview, including confessionally oriented forms of psychotherapeutic intervention; issues of instrumental clinical assessment of religiosity are also addressed. The analyzed data substantiate the necessity of conducting a targeted comprehensive study of depressive-delusional states with religious content, incorporating clinical and clinical-follow-up components, aimed at the development of differentiated approaches to the treatment and rehabilitation of this patient population.
- 21 November 2025
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 125 (10) , 32-37
Psychopathological features of obsessive-compulsive disorder with religious content in young men
Objective. To identify clinical and psychopathological features of obsessive-compulsive disorder (OCD) with religious content in young men and develop a clinical typology of these conditions. Material and methods. Clinical, psychopathological, psychometric, and statistical methods were used to study 33 young men (16—25 years) diagnosed with OCD (F42) with religious content of obsessions. Results. Three typological forms have been identified, depending on the clinical and psychopathological characteristics dominant in each type of OCD: obsessive thoughts about spiritual imperfection, fear of sinning (21.2%), dominant blasphemous thoughts (63.6%), and obsessive religious perfectionism (15.2%). Premorbidly, among all the studied cases, schizoid and psychasthenic personalities were the most common. The mean age of onset of OCD with religious content was 17±1.2 years. The ratio of depressive and obsessive-compulsive symptoms correlated within each of the typological forms. Conclusion. The data obtained demonstrated the clinical heterogeneity of OCD with religious content. The described typological forms differed in the premorbid period, OCD phenomenology, and comorbid (depressive) symptoms. Further study of the clinical and follow-up groups is planned to investigate the patterns of these conditions’ courses.
- 21 November 2025
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 125 (10) , 32-37
Psychopathological features of obsessive-compulsive disorder with religious content in young men
Objective. To identify clinical and psychopathological features of obsessive-compulsive disorder (OCD) with religious content in young men and develop a clinical typology of these conditions. Material and methods. Clinical, psychopathological, psychometric, and statistical methods were used to study 33 young men (16—25 years) diagnosed with OCD (F42) with religious content of obsessions. Results. Three typological forms have been identified, depending on the clinical and psychopathological characteristics dominant in each type of OCD: obsessive thoughts about spiritual imperfection, fear of sinning (21.2%), dominant blasphemous thoughts (63.6%), and obsessive religious perfectionism (15.2%). Premorbidly, among all the studied cases, schizoid and psychasthenic personalities were the most common. The mean age of onset of OCD with religious content was 17±1.2 years. The ratio of depressive and obsessive-compulsive symptoms correlated within each of the typological forms. Conclusion. The data obtained demonstrated the clinical heterogeneity of OCD with religious content. The described typological forms differed in the premorbid period, OCD phenomenology, and comorbid (depressive) symptoms. Further study of the clinical and follow-up groups is planned to investigate the patterns of these conditions’ courses.
- Open Access
- 8 November 2024
- Published by Medical Informational Agency Publishers in Psychiatry (Moscow) (Psikhiatriya)
- Vol. 22 (4) , 74-84
Treatment Tactics in Remission Stage of Episodic Schizophrenia Taking into Account Immunological Parameters
Background: the study of clinical remission in schizophrenia has a significant place at the current stage of development of psychiatric science. Prevention therapy and personalized prophylactic therapy is important to improve the quality of remission, stabilization of the endogenous process and prevention of exacerbation. The aim was to develop apathogenetically grounded method of treatment of episodic schizophrenia at the remission stage using complex assessment of clinical, psychometric and immunological parameters of patients, which allows to control the quality and stability of remission, as well as prediction of exacerbation of the endogenous process. Patients and methods: 91 patients (24 men and 67 women) aged from 18 to 70 years were examined. They were in remission after suffering attacks of an endogenous disease with episodic course (the duration of remissions ranged from 6 months to 12 years). Clinical-psychopathological, psychometric, immunological, clinical and followup, and statistical methods were used. Results: determination of inflammatory and autoimmune markers of blood plasma in the dynamics of the disease and their comparison with the severity of psychopathological symptomatology of patients with schizophrenia, made it possible to form 2 groups of patients with differently directed correlations between the change in clinical state (according to the PANSS scale) and the level of activation of the immune system, assessed in the aggregate immune markers determined. For patients of group 1 (n = 58; 63.74%) the decrease of the intensity of psychopathological symptoms in remission is associated with a decrease in the level of immune system activation («positive» correlations). For the patients of group 2 (n = 33; 36.26%) the level of immune system activation in remission does not decrease and remains at the level of the acute stage of the disease (“negative” correlations). It is shown that the increase in the level of immune system activation in patients of group 1 is a prognostic immunological criterion of possible exacerbation of psychopathological symptoms in remission. Based on the determination of immunological blood parameters in remission, personalized treatment tactics have been developed for these patients, associated with the transition from maintenance doses of drugs to therapeutic ones or additional use of drugs of another group. In most cases, this tactic contributed to relatively favorable dynamics of the existing clinical remission without significant changes in the condition. For patients of group 2, the personalized therapy tactics involves continuation of longterm active therapy. Conclusions: complex assessment of clinical, psychometric and immunological parameters of patients with episodic schizophrenia, which allows to control the quality and stability of remission, can be used to control the quality and stability of remission, as well as to detect preclinical signs of exacerbation of the endogenous process.
- 8 November 2024
- Published by Medical Informational Agency Publishers in Psychiatry (Moscow) (Psikhiatriya)
- Vol. 22 (4) , 74-84
Open AccessTreatment Tactics in Remission Stage of Episodic Schizophrenia Taking into Account Immunological Parameters
Background: the study of clinical remission in schizophrenia has a significant place at the current stage of development of psychiatric science. Prevention therapy and personalized prophylactic therapy is important to improve the quality of remission, stabilization of the endogenous process and prevention of exacerbation. The aim was to develop apathogenetically grounded method of treatment of episodic schizophrenia at the remission stage using complex assessment of clinical, psychometric and immunological parameters of patients, which allows to control the quality and stability of remission, as well as prediction of exacerbation of the endogenous process. Patients and methods: 91 patients (24 men and 67 women) aged from 18 to 70 years were examined. They were in remission after suffering attacks of an endogenous disease with episodic course (the duration of remissions ranged from 6 months to 12 years). Clinical-psychopathological, psychometric, immunological, clinical and followup, and statistical methods were used. Results: determination of inflammatory and autoimmune markers of blood plasma in the dynamics of the disease and their comparison with the severity of psychopathological symptomatology of patients with schizophrenia, made it possible to form 2 groups of patients with differently directed correlations between the change in clinical state (according to the PANSS scale) and the level of activation of the immune system, assessed in the aggregate immune markers determined. For patients of group 1 (n = 58; 63.74%) the decrease of the intensity of psychopathological symptoms in remission is associated with a decrease in the level of immune system activation («positive» correlations). For the patients of group 2 (n = 33; 36.26%) the level of immune system activation in remission does not decrease and remains at the level of the acute stage of the disease (“negative” correlations). It is shown that the increase in the level of immune system activation in patients of group 1 is a prognostic immunological criterion of possible exacerbation of psychopathological symptoms in remission. Based on the determination of immunological blood parameters in remission, personalized treatment tactics have been developed for these patients, associated with the transition from maintenance doses of drugs to therapeutic ones or additional use of drugs of another group. In most cases, this tactic contributed to relatively favorable dynamics of the existing clinical remission without significant changes in the condition. For patients of group 2, the personalized therapy tactics involves continuation of longterm active therapy. Conclusions: complex assessment of clinical, psychometric and immunological parameters of patients with episodic schizophrenia, which allows to control the quality and stability of remission, can be used to control the quality and stability of remission, as well as to detect preclinical signs of exacerbation of the endogenous process.
- Open Access
- 7 November 2024
- Published by Medical Informational Agency Publishers in Psychiatry (Moscow) (Psikhiatriya)
- Vol. 22 (4) , 26-33
Systematics of the Forms of Schizophrenia in the Concept of AV. Snezhnevsky
Background: Although there are international classifications of schizophrenia, the clinical approach to the systematization of schizophrenia developed by russian scientists has not lost its signifcance to date. The main role in the development of the schizophrenia of the national psychiatric school belongs to the famous Russian psychiatrist A.V. Snezhnevsky and his colleagues. The aim of review: to analyze the forms of the course of schizophrenia according to the concept of A.V. Snezhnevsky. Materials and methods: review of the main publications of A.V. Snezhnevsky and colleagues on the question of the doctrine of forms of schizophrenia course. Conclusion: The review summarizes the main research results of the national psychiatric school under the leadership of academician A.V. Snezhnevsky in the formation of the doctrine of schizophrenia.
- 7 November 2024
- Published by Medical Informational Agency Publishers in Psychiatry (Moscow) (Psikhiatriya)
- Vol. 22 (4) , 26-33
Open AccessSystematics of the Forms of Schizophrenia in the Concept of AV. Snezhnevsky
Background: Although there are international classifications of schizophrenia, the clinical approach to the systematization of schizophrenia developed by russian scientists has not lost its signifcance to date. The main role in the development of the schizophrenia of the national psychiatric school belongs to the famous Russian psychiatrist A.V. Snezhnevsky and his colleagues. The aim of review: to analyze the forms of the course of schizophrenia according to the concept of A.V. Snezhnevsky. Materials and methods: review of the main publications of A.V. Snezhnevsky and colleagues on the question of the doctrine of forms of schizophrenia course. Conclusion: The review summarizes the main research results of the national psychiatric school under the leadership of academician A.V. Snezhnevsky in the formation of the doctrine of schizophrenia.
- Open Access
- 24 July 2024
- Published by Medical Informational Agency Publishers in Psychiatry (Moscow) (Psikhiatriya)
- Vol. 22 (3) , 24-33
Mood Disorders in Schizotypal Disorder with Leading Syndrome of Eating Disorders
Background: сoverage of the problem of mood disorders in patients with schizotypal disorder with leading eating disorders (EDs), in childhood and adolescence is relevant. However, concomitant disorders in eating disorder in childhood and adolescence and their dynamics have not been sufficiently studied. The aim: to study the clinical and psychopathological structure of mood disorders in patients with schizotypal disorder and eating disorders leading in the clinical picture. Patients and methods: the study included 50 patients (9 boys, 41 girls), aged 7 to 16 years. Inclusion criteria: 1) schizotypal disorder; 2) eating disorders; 3) mood disorders. Research methods: clinical-psychopathological, psychometric (HDRS, PANSS), follow-up, somatic observation. Results: in patients with schizotypal and mood disorders, the following variants of eating disorder were observed: anorexia nervosa (AN — first type), anorexia nervosa with dominance of bulimia (ANB — second type), anorexia nervosa with dominance of bulimia and vomitomania (ANB + B — third type). Mood disorders in the first type of eating disorder were characterized by a pronounced depressive triad, suicidal thoughts and stupor at the cachectic stage of the disease. Mood disorders in the second type of eating disorder were characterized by a mixed affective state: short unproductive mania, ideas of dysmorphophobia, ideas of attitude, followed by a prolonged depressive state with senesto-hypochondriacal disorders, asthenia, and an increase in cognitive impairment. Mood disorders in the third type of eating disorder were characterized by the presence, of pronounced delusional and dysmorphophobic disorders and ideas of attitude, psychopathic behavior, depersonalization-derealization disorders, asthenia and cognitive impairment. Affective pathology in schizotypal disorder with eating disorder, as well as body dysmorphic syndrome, persisted for a long time. The most severe course was observed in the third group of patients (NANB + B), which was due to a significant proportion of psychotic disorders in the structure of the syndrome and somatic complications due to vomiting behavior. Conclusions: patients with schizotypal disorder with leading symptoms of eating disorder and mood disorders require an integrated approach to therapy, including somatic and psychopharmacological treatment.
- 24 July 2024
- Published by Medical Informational Agency Publishers in Psychiatry (Moscow) (Psikhiatriya)
- Vol. 22 (3) , 24-33
Open AccessMood Disorders in Schizotypal Disorder with Leading Syndrome of Eating Disorders
Background: сoverage of the problem of mood disorders in patients with schizotypal disorder with leading eating disorders (EDs), in childhood and adolescence is relevant. However, concomitant disorders in eating disorder in childhood and adolescence and their dynamics have not been sufficiently studied. The aim: to study the clinical and psychopathological structure of mood disorders in patients with schizotypal disorder and eating disorders leading in the clinical picture. Patients and methods: the study included 50 patients (9 boys, 41 girls), aged 7 to 16 years. Inclusion criteria: 1) schizotypal disorder; 2) eating disorders; 3) mood disorders. Research methods: clinical-psychopathological, psychometric (HDRS, PANSS), follow-up, somatic observation. Results: in patients with schizotypal and mood disorders, the following variants of eating disorder were observed: anorexia nervosa (AN — first type), anorexia nervosa with dominance of bulimia (ANB — second type), anorexia nervosa with dominance of bulimia and vomitomania (ANB + B — third type). Mood disorders in the first type of eating disorder were characterized by a pronounced depressive triad, suicidal thoughts and stupor at the cachectic stage of the disease. Mood disorders in the second type of eating disorder were characterized by a mixed affective state: short unproductive mania, ideas of dysmorphophobia, ideas of attitude, followed by a prolonged depressive state with senesto-hypochondriacal disorders, asthenia, and an increase in cognitive impairment. Mood disorders in the third type of eating disorder were characterized by the presence, of pronounced delusional and dysmorphophobic disorders and ideas of attitude, psychopathic behavior, depersonalization-derealization disorders, asthenia and cognitive impairment. Affective pathology in schizotypal disorder with eating disorder, as well as body dysmorphic syndrome, persisted for a long time. The most severe course was observed in the third group of patients (NANB + B), which was due to a significant proportion of psychotic disorders in the structure of the syndrome and somatic complications due to vomiting behavior. Conclusions: patients with schizotypal disorder with leading symptoms of eating disorder and mood disorders require an integrated approach to therapy, including somatic and psychopharmacological treatment.
- Open Access
- 23 July 2024
- Published by Medical Informational Agency Publishers in Psychiatry (Moscow) (Psikhiatriya)
- Vol. 22 (3) , 14-23
Comparative Characteristics of Inflammatory Markers in Alzheimer’s Disease in Males and Females
Background: the role of the sex factor in the differences between the manifestations of normality and pathology is not limited to the phenomenon of sexual dimorphism. It is known that the prevalence of certain diseases in males and females is different, in particular, there is a multiple increase in the incidence of dementia in females compared to males in Alzheimer’s disease (AD). Taking into account the role of neuroinflammation in the pathogenesis of neurodegenerative diseases, there is reason to assume gender differences in inflammation indicators at different stages of dementia in AD. The aim of the study was to conduct comparative analysis of indicators of the inflammatory system in the blood plasma of males and females at different stages of Alzheimer’s disease. Patients, control group and methods: a total of 210 patients with AD (101 males and 109 females) aged 49 to 94 years (average age 72.3 ± 8.2) with varying degrees of dementia severity, i.e. mild, moderate, severe, were examined. In peripheral blood plasma, the enzymatic activity of leukocyte elastase (LE) and the functional activity of α1-proteinase inhibitor (α1-PI) were determined by the spectrophotometric method, and the level of C-reactive protein (CRP) and IL-6 were determined by the enzyme-linked immunosorbent method (ELISA). The control group consisted of 52 healthy people, who did not differ from the patients in age and gender. Results and discussion: in the blood of patients with varying severity of dementia in AD, a statistically significant increase in α1-PI activity was observed compared to controls (p < 0.0001), regardless of gender. For all subgroups of patients with AD, the indicators of LE enzymatic activity were within the control range or beyond its lower limit. Low LE activity was observed in males compared to females both in the general group and in moderate dementia (p = 0.005105, p = 0.028672, respectively). In severe dementia, a significant decrease in LE activity compared to the controls did not depend on gender. Low LE activity in the blood of patients with AD, along with elevated levels of other inflammatory markers, may reflect a critical violation of the permeability of the blood-brain barrier and/or functional exhaustion of neutrophils due to a long-term inflammatory process. In males, compared with females, an increase in the level of the pro-inflammatory cytokine IL-6 was detected in the general group and in moderate dementia (p = 0.021238, p = 0.027894, respectively). A highly significant increase in CRP levels was only detected in males in subgroups with different severity of dementia. CRP levels in males were significantly higher than in females at the stage of moderate and severe dementia (p = 0.000906, p = 0.000049, respectively). Conclusion: distinctive features of inflammatory markers spectrum were identified, depending on gender and severity of dementia in AD. These results can be used to develop sex-specific preventive or therapeutic strategies for patients with mild cognitive impairment to determine risk and resistance to developing dementia.
- 23 July 2024
- Published by Medical Informational Agency Publishers in Psychiatry (Moscow) (Psikhiatriya)
- Vol. 22 (3) , 14-23
Open AccessComparative Characteristics of Inflammatory Markers in Alzheimer’s Disease in Males and Females
Background: the role of the sex factor in the differences between the manifestations of normality and pathology is not limited to the phenomenon of sexual dimorphism. It is known that the prevalence of certain diseases in males and females is different, in particular, there is a multiple increase in the incidence of dementia in females compared to males in Alzheimer’s disease (AD). Taking into account the role of neuroinflammation in the pathogenesis of neurodegenerative diseases, there is reason to assume gender differences in inflammation indicators at different stages of dementia in AD. The aim of the study was to conduct comparative analysis of indicators of the inflammatory system in the blood plasma of males and females at different stages of Alzheimer’s disease. Patients, control group and methods: a total of 210 patients with AD (101 males and 109 females) aged 49 to 94 years (average age 72.3 ± 8.2) with varying degrees of dementia severity, i.e. mild, moderate, severe, were examined. In peripheral blood plasma, the enzymatic activity of leukocyte elastase (LE) and the functional activity of α1-proteinase inhibitor (α1-PI) were determined by the spectrophotometric method, and the level of C-reactive protein (CRP) and IL-6 were determined by the enzyme-linked immunosorbent method (ELISA). The control group consisted of 52 healthy people, who did not differ from the patients in age and gender. Results and discussion: in the blood of patients with varying severity of dementia in AD, a statistically significant increase in α1-PI activity was observed compared to controls (p < 0.0001), regardless of gender. For all subgroups of patients with AD, the indicators of LE enzymatic activity were within the control range or beyond its lower limit. Low LE activity was observed in males compared to females both in the general group and in moderate dementia (p = 0.005105, p = 0.028672, respectively). In severe dementia, a significant decrease in LE activity compared to the controls did not depend on gender. Low LE activity in the blood of patients with AD, along with elevated levels of other inflammatory markers, may reflect a critical violation of the permeability of the blood-brain barrier and/or functional exhaustion of neutrophils due to a long-term inflammatory process. In males, compared with females, an increase in the level of the pro-inflammatory cytokine IL-6 was detected in the general group and in moderate dementia (p = 0.021238, p = 0.027894, respectively). A highly significant increase in CRP levels was only detected in males in subgroups with different severity of dementia. CRP levels in males were significantly higher than in females at the stage of moderate and severe dementia (p = 0.000906, p = 0.000049, respectively). Conclusion: distinctive features of inflammatory markers spectrum were identified, depending on gender and severity of dementia in AD. These results can be used to develop sex-specific preventive or therapeutic strategies for patients with mild cognitive impairment to determine risk and resistance to developing dementia.
- Open Access
- 23 May 2024
- Published by Medical Informational Agency Publishers in Psychiatry (Moscow) (Psikhiatriya)
- Vol. 22 (2) , 6-17
Structural and Functional Characteristics of the Dorsolateral Prefrontal Cortex in Schizophrenia Spectrum Disorders and Their Associations with Onset Age
Background: the dorsolateral prefrontal cortex (DLPFC) is one of the latest brain structures to mature during the ontogeny, and its structural and functional abnormalities play an important role in the pathogenesis of schizophrenia. As schizophrenia spectrum disorders usually start before the complete brain maturation and their earlier onset is coupled with worse prognosis, we suggested that earlier illness onset is related to more pronounced aberrations of the DLPFC. The aim of study was to analyze the associations of the onset age of schizophrenia spectrum disorders with structural and functional characteristics of the DLPFC that differentiated patients with schizophrenia spectrum disorders from healthy controls. Patients and methods: male patients with a diagnosis of schizophrenia spectrum disorders (n = 82) and healthy controls (n = 86) underwent structural MRI and functional resting-state fMRI. Cortical thickness and whole-brain functional connectivity of the DLPFC as well as local coherence and amplitude of low-frequency fluctuations of haemodynamic signal in the DLPFC were analyzed. Results: patients demonstrated a decreased gray matter thickness in the DLPFC bilaterally along with aberrant (predominantly decreased) functional connectivity of the DLPFC with other brain structures in each hemisphere. These measures were not associated with the age of illness onset. Conclusions: structural and functional abnormalities revealed in this study coincide with conventional view on the DLPFC as one of the key regions in schizophrenia spectrum disorders pathogenesis, however, these aberrations were not related to the age of psychosis onset. Possible interpretations of our results and limitations of the study are discussed in the article.
- 23 May 2024
- Published by Medical Informational Agency Publishers in Psychiatry (Moscow) (Psikhiatriya)
- Vol. 22 (2) , 6-17
Open AccessStructural and Functional Characteristics of the Dorsolateral Prefrontal Cortex in Schizophrenia Spectrum Disorders and Their Associations with Onset Age
Background: the dorsolateral prefrontal cortex (DLPFC) is one of the latest brain structures to mature during the ontogeny, and its structural and functional abnormalities play an important role in the pathogenesis of schizophrenia. As schizophrenia spectrum disorders usually start before the complete brain maturation and their earlier onset is coupled with worse prognosis, we suggested that earlier illness onset is related to more pronounced aberrations of the DLPFC. The aim of study was to analyze the associations of the onset age of schizophrenia spectrum disorders with structural and functional characteristics of the DLPFC that differentiated patients with schizophrenia spectrum disorders from healthy controls. Patients and methods: male patients with a diagnosis of schizophrenia spectrum disorders (n = 82) and healthy controls (n = 86) underwent structural MRI and functional resting-state fMRI. Cortical thickness and whole-brain functional connectivity of the DLPFC as well as local coherence and amplitude of low-frequency fluctuations of haemodynamic signal in the DLPFC were analyzed. Results: patients demonstrated a decreased gray matter thickness in the DLPFC bilaterally along with aberrant (predominantly decreased) functional connectivity of the DLPFC with other brain structures in each hemisphere. These measures were not associated with the age of illness onset. Conclusions: structural and functional abnormalities revealed in this study coincide with conventional view on the DLPFC as one of the key regions in schizophrenia spectrum disorders pathogenesis, however, these aberrations were not related to the age of psychosis onset. Possible interpretations of our results and limitations of the study are discussed in the article.
- 23 April 2024
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 124 (11) , 55-63
Evolution of views on the phenomenon of spiritual possession within the framework of psychiatric pathology (psychopathological, transnosological and transcultural aspects)
The spiritual possession phenomenon (SPP), is a complex transnosological, transcultural syndrome, which is based on the patients’ perception that some spiritual entity (spirit, demon, jinn, shaitan, «ikotka», dybbuk, Buddha, etc.) is influencing or possessing them. Modern classifications of diseases, aimed at expanding our ideas about the distinction between the norm and pathology of mental disorders, do not contribute to a clear psychopathological differentiation of SPP, the determination of its nosological affiliation and the choice of appropriate therapeutic tactics for these conditions. To date, there is no unity of ideas about SPP among psychiatrists, and the conflict between different interpretations of the phenomenon persists. The aim of this review was to analyze scientific studies devoted to the SPP within the framework of psychiatric pathology in mature age patients, in order to differentiate the underlying psychopathological disorders, to determine the nosological affiliation and the specific therapeutic approaches of these conditions. The keywords «mental disorder spirit possession», «possession dissociative identity disorder», «delusion of possession» were searched in the electronic databases eLibrary and PubMed, as well as in the Russian State Library and the scientific library of the Mental Health Research Center, publications of Russian and foreign researchers for the period from the 3s of the XIX century to the present time were selected and analyzed. The dynamics of psychiatric views on the SPP within the framework of mental disorders over time was assessed. The study of the SPP remains a challenging multidisciplinary problem for contemporary scientific research. The SPP requires further deep interdisciplinary understanding, detailed clinical and psychopathological analysis and final determination of its place in clinical psychiatry.
- 23 April 2024
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 124 (11) , 55-63
Evolution of views on the phenomenon of spiritual possession within the framework of psychiatric pathology (psychopathological, transnosological and transcultural aspects)
The spiritual possession phenomenon (SPP), is a complex transnosological, transcultural syndrome, which is based on the patients’ perception that some spiritual entity (spirit, demon, jinn, shaitan, «ikotka», dybbuk, Buddha, etc.) is influencing or possessing them. Modern classifications of diseases, aimed at expanding our ideas about the distinction between the norm and pathology of mental disorders, do not contribute to a clear psychopathological differentiation of SPP, the determination of its nosological affiliation and the choice of appropriate therapeutic tactics for these conditions. To date, there is no unity of ideas about SPP among psychiatrists, and the conflict between different interpretations of the phenomenon persists. The aim of this review was to analyze scientific studies devoted to the SPP within the framework of psychiatric pathology in mature age patients, in order to differentiate the underlying psychopathological disorders, to determine the nosological affiliation and the specific therapeutic approaches of these conditions. The keywords «mental disorder spirit possession», «possession dissociative identity disorder», «delusion of possession» were searched in the electronic databases eLibrary and PubMed, as well as in the Russian State Library and the scientific library of the Mental Health Research Center, publications of Russian and foreign researchers for the period from the 3s of the XIX century to the present time were selected and analyzed. The dynamics of psychiatric views on the SPP within the framework of mental disorders over time was assessed. The study of the SPP remains a challenging multidisciplinary problem for contemporary scientific research. The SPP requires further deep interdisciplinary understanding, detailed clinical and psychopathological analysis and final determination of its place in clinical psychiatry.
- 23 April 2024
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 124 (6) , 15-19
Features of cognitive impairment in bipolar affective disorder
The study of cognitive impairment in bipolar disorder (BD) combined with anxiety-phobic disorders, as the most common comorbid pathology, is a new, little-studied and relevant direction for further research on BD, promising for clarifying the neurobiological mechanisms of the disease and improving the quality of the diagnostic process. By searching for combinations of the keywords «bipolar disorder», «anxiety disorders», «cognitive impairment», «cognitive dysfunction», «meta-analysis» and «review» in the databases «PubMed» and «Google Scholar», meta-analyses, analytical, review and original relevant research articles were identified. A generalization of the information accumulated in the literature indicates a) the presence in BD of both phase-dependent and persistent cognitive impairments that also occur during the period of euthymia, b) different structure and severity of neurocognitive disorders in cases of «pure» BD and anxiety-phobic disorders, c) the unique structure of cognitive impairment in BD with comorbid anxiety-phobic disorders, which incorporates the features of neurocognitive impairments that are characteristic of both disorders and have the greatest severity compared to them. The results of this review are of interest for planning further empirical studies of this topic on the Russian patient population.
- 23 April 2024
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 124 (6) , 15-19
Features of cognitive impairment in bipolar affective disorder
The study of cognitive impairment in bipolar disorder (BD) combined with anxiety-phobic disorders, as the most common comorbid pathology, is a new, little-studied and relevant direction for further research on BD, promising for clarifying the neurobiological mechanisms of the disease and improving the quality of the diagnostic process. By searching for combinations of the keywords «bipolar disorder», «anxiety disorders», «cognitive impairment», «cognitive dysfunction», «meta-analysis» and «review» in the databases «PubMed» and «Google Scholar», meta-analyses, analytical, review and original relevant research articles were identified. A generalization of the information accumulated in the literature indicates a) the presence in BD of both phase-dependent and persistent cognitive impairments that also occur during the period of euthymia, b) different structure and severity of neurocognitive disorders in cases of «pure» BD and anxiety-phobic disorders, c) the unique structure of cognitive impairment in BD with comorbid anxiety-phobic disorders, which incorporates the features of neurocognitive impairments that are characteristic of both disorders and have the greatest severity compared to them. The results of this review are of interest for planning further empirical studies of this topic on the Russian patient population.